Fachbeitrag Literatur [1] Schönberg, L., Grobosch, T., Lampe, D.
and Kloft, C.
Toxicological Screening in Urine: Comparison of Two Automated HPLC Screening Systems, Toxicological Iden- tifi cation System (TOX.I.S) versus REMEDITM-HS, J.
Anal.
Toxicol.
31:321-327 (2007).
[2] Guan, F., Seno, H., Ishii, A., Watanabe, K., Kumaszawa, T., Hattori, H., Suzuki, O.
Solid-phase microextraction and GC-ECD of benzophenones for detection of benzo- diazepines in urine, J.
Anal.
Toxicol., 23: 54-61, 1999.
[3] Mullett, M.
W., Pawliszyn, J.
Direct LC analysis of fi ve benzodiazepines in human urine and plasma using an ADS restricted access extraction column, J.
Pharm.
Bio- med.
Anal.
26: 899-908, 2001.
[4] Drummer, O.
H., Methods for the measurement of ben- zodiazepines in biological samples, J.
Chromatogr.
B Biomed.
Sci.
Appl.
713: 201-225, 1998.
[5] Külpmann, W.
R.
(ed.): Clinical Toxicological Analysis, Procedures, Results, Interpretation, 1.
Edition - March 2009, 926 Pages, 2 Volumes, Hardcover, Wiley-VCH, Weinheim.
[6] Klette K.
L., Wiegand R.
F., Horn C.
K., Stout P.
R., Mag- luilo J.
Jr.
Urine benzodiazepine screening using Roche Online KIMS immunoassay with beta-glucuronidase hy- drolysis and confi rmation by gas chromatography - mass spectrometry.
J.
Anal.
Toxicol.
29 (3): 193-200 (2005).
[7] Samanidou V.
F., Pechlivanidou A.
P., Papadoyannis I.
N.
Development of a validated HPLC method for the determination of four 1,4-benzodiazepines in human biological fl uids.
J Sep Sci.
2007 Mar 30(5):679-87.
[8] Marin S.
J., Coles R., Merrell M., McMillin G.
A.
Quanti- tation of benzodiazepines in urine, serum, plasma, and meconium by LC-MS-MS.
J.
Anal.
Toxicol.
32(7):491-8 (2008).
[9] ElSohly M.
A., Gul W., Murphy T.
P., Avula B., Khan I.
A.
LC-(TOF) MS analysis of benzodiazepines in urine from alleged victims of drug-facilitated sexual assault.
J.
Anal.
Toxicol.
31(8):505-14 (2007).
[10] Miki A., Tatsuno M., Katagi M., Nishikawa M., Tsuchi- hashi H.
Simultaneous determination of eleven benzo- diazepine hypnotics and eleven relevant metabolites in urine by column-switching liquid chromatography- mass spectrometry.
J.
Anal.
Toxicol.
26(2):87-93 (2002).
[11] Pragst, F., Herzler M., Herre, S., Erxleben, B.-T., Rothe, M.
UV Spectra of Toxic Compounds, Toxicological Chemistry.
[12] http://www.epsy.de/psychiatrie/psychopharma- ka.htm.
Zugriffsdatum 15.09.09.
[13] Ramrakha P., Moore K.
(2004): „Chapter 14: Drug overdoses“.
Oxford Handbook of Acute Medicine (2nd ed.).
Oxford University Press.
p.
791-838,(798).
ISBN 0198520727.
Flexibel.
Verlässlich.
Persönlich.
FoodALYT FoodALYT RT nach Twisselmann • Hohe Energieeffizienz • Einsparung von Lösungsmitteln • Mehr Sicherheit im Labor Robert-Hooke-Str.
8 · 28359 Bremen Telefon 04 21 / 1 75 99-372 Telefax 04 21 / 1 75 99-370 www.omnilab.de · oas@omnilab.de K O M P E T E N Z I M L A B O R Bild 6: UV-Spektren Lorazepam (Similarität = 0,999844).
82 ?? LABOLABO Toxikologisches Identifi zierungssystem TOX.
I.S ?? 180 ? Shimadzu, Duisburg, Tel.
0203/7687-0, Fax 711734, www.shimadzu.com
